Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.

by Jessica Nyström, Jenny Stenkvist, Amanda Häggblom, Ola Weiland, Piotr Nowak
Published 2015-01-01

The dynamic relationship between innate immune biomarkers and interferon-based treatment effects and outcome in hepatitis C virus infection is altered by telaprevir.

by David F G Malone, Karolin Falconer, Ola Weiland, Johan K Sandberg
Published 2014-01-01

Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection.

by Magdalena Ydreborg, Johan Westin, Karolina Rembeck, Magnus Lindh, Hans Norrgren, Anna Holmberg, Rune Wejstål, Gunnar Norkrans, Kristina Cardell, Ola Weiland, Martin Lagging
Published 2013-01-01

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.

by Olav Dalgard, Ola Weiland, Geir Noraberg, Lars Karlsen, Lars Heggelund, Martti Färkkilâ, Ulla Balslev, Erika Belard, Anne Øvrehus, Mette Skalshøi Kjær, Henrik Krarup, Birgit Thorup Røge, Sofie Hallager, Lone G Madsen, Alex Lund Laursen, Martin Lagging, Nina Weis
Published 2017-01-01